🩺 Endocrine Disorder Management: Diagnosis and Treatment Modalities in the Acromegaly Market
The Acromegaly Market focuses on the diagnosis and therapeutic management of acromegaly, a rare chronic endocrine disorder caused by the overproduction of growth hormone (GH) by a pituitary adenoma, leading to excessive levels of Insulin-like Growth Factor-1 (IGF-1). This results in the abnormal growth of hands, feet, and facial features, and is associated with severe comorbidities like...
0 Comments 0 Shares 115 Views 0 Reviews